继发性肌少症的中西医结合治疗研究进展

摘要/Abstract

摘要： 继发性肌少症是一种常见的神经肌肉疾病,常见于中老年患者。该病的发生率较高,以肌肉质量减少及肌肉力量下降为主要表现,病因复杂,临床表现多种多样,同时临床医生对此疾病的重视程度不足,未能进行早期干预治疗,最终严重影响患者的远期生活。尽管继发性肌少症的病因和病理机制尚不完全清楚,但在中西医结合的研究中,取得了一些重要进展。本综述将对继发性肌少症的中西医结合研究进展进行综合介绍,以期为该病的诊断和治疗提供一些参考。

关键词: 继发性肌少症, 康复, 针灸, 中药

Abstract: Secondary muscular atrophy(SMA) is a common neuromuscular disease, commonly seen in middle-aged and elderly patients. The incidence of this disease is relatively high, with a decrease in muscle mass and muscle strength as the main manifestations. The etiology is complex and the clinical manifestations are diverse. At the same time, clinical doctors do not pay enough attention to this disease and fail to provide early intervention and treatment, which can ultimately seriously affect the long-term survival of patients. Although the etiology and pathological mechanism of SMA are not fully understood, significant progress has been made in the study of integrated traditional Chinese and Western medicine. This review will comprehensively introduce the research progress of the combination of traditional Chinese and Western medicine in SMA, in order to provide some reference for the diagnosis and treatment of this disease.

Key words: secondary muscular atrophy, rehabilitation, acupuncture, Chinese medicine

中图分类号:

R685

董旭, 冯涛. 继发性肌少症的中西医结合治疗研究进展[J]. 中华养生保健, 2024, 42(9): 77-79.

DONG Xu, FENG Tao. Review of Research Progress of the Combination of Traditional Chinese and Western Medicine in Secondary Sarcopenia[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(9): 77-79.

参考文献

[1] PACIFICO J, GEERLINGS M A J, REIJNIERSE E M, et al. Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis[J]. Exp Gerontol,2020,131(3): 1-19.
[2] CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing,2019, 48(4): 601.
[3] ALBANO D, MESSINA C, VITALE J, et al.Imaging of sarcopenia:old evidence and new insights[J]. Eur Radiol,2020, 30(4):2199-2208.
[4] 齐涵,赵洪欣,孟凯华,等.中医药治疗老年肌少症研究进展[J].中医药导报,2020,26(13):179-182.
[5] CHEN L K, WOO J, ASSANTACHAI P, et al.Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc 2020, 21(3): 300-307.
[6] ALBANO D, MESSINA C, VITALE J, et al.Imaging of sarcopenia: Old evidence and new insights[J]. Eur Radiol,2020, 30(4): 2199-2208.
[7] 汪涛,杨敏春,任璇璇.老年骨骼肌减少症中医理法探究[J].新中医,2017,49(11):149-151.
[8] MATSUO S, KAWAKAMI M, MINETAMA M, et al.Clinical features of sarcopenia in patients with lumbar spinal stenosis[J]. Spine (Phila Pa 1976),2020, 45(17): E1105-E1110.
[9] WONG R M Y, WONG H, ZHANG N, et al. The relationship between sarcopenia and fragility fracture-a systematic review[J]. Osteoporos Int,2019, 30(3): 541-553.
[10] WAGNER P, CHAPURLAT R, ECOCHARD R, et al.Low muscle strength and mass is associated with the accelerated decline of bone microarchitecture at the distal radius in older men: The prospective STRAMBO study[J]. J Bone Miner Res,2018, 33(9): 1630-1640.
[11] TANAKA K I, XUE Y, NGUYEN-YAMAMOTO L, et al.FAM210A is a novel determinant of bone and muscle structure and strength[J]. Proc Natl Acad Sci U S A,2018, 115(16): E3759-E3768.
[12] MATTERA M, REGINELLI A, BARTOLLINO S, et al.Imaging of metabolic bone disease[J]. Acta Biomed,2018, 89(1-S): 197-207.
[13] LO J H, U K P, YIU T, et al. Sarcopenia: Current treatments and new regenerative therapeutic approaches[J]. J Orthop Translat,2020, 23(7): 38-52.
[14] LE X, WEI Y, HAO D, et al.Psychometric properties of the Chinese version of the sarcopenia and quality of life,a quality of life questionnaire specific for sarcopenia[J]. Calcif Tissue Int,2021,109(4): 415-422.
[15] TANG T C, HWANG A C, LIU L K, et al.FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in taiwan: results from I-Lan longitudinal aging study[J]. J Gerontol A Biol Sci Med Sci,2018,73(6) : 828-834.
[16] 杨玲,杜娟,刘荣雁,等.肌肉减少症病因学研究现状与展望[J].中国骨质疏松杂志,2020,26(11):1689-1693.
[17] GEERINCK A, BEAUDART C, REGINSTER J Y, et al.Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL[J]. Qual Life Res,2021,30(8):2349-2362.
[18] BEAUDART C, EDWARDS M, MOSS C, et al.English translation and validation of the SarQoL®,a quality of life questionnaire specific for sarcopenia[J]. Age Ageing,2017,46(2):271-276.
[19] KONSTANTYNOWICZ J, ABRAMOWICZ P, GLINKOWSKI W, et al.Polish validation of the SarQoL®, a quality of life questionnaire specific to sarcopenia[J]. J Clin Med,2018,7(10):323.
[20] 王文慧,沈雁,史晓,等.基于中医理论探讨老年衰弱综合征[J].新中医,2021,53(3):195-198.
[21] 张欣怡,罗涛,韩珂,等.从“治痿独取阳明”论治肌少症[J].中西医结合研究. 2023,15(1):63-65.
[22] 王越,唐琳,徐筱玮.基于脾肾相关理论探讨老年糖尿病肌少症[J].中医学报,2022,37(2):249-253.
[23] 李怡. 老年肌肉衰减综合征中西医结合防治[J].中国中西医结合杂志,2021,41(9):1032-1035.
[24] 刘娟,丁清清,周白瑜,等.中国老年人肌少症诊疗专家共识( 2021)[J].中华老年医学杂志,2021,40(8):943-952.
[25] 王贤良,莫欣宇,王帅,等.八段锦对稳定性冠心病患者运动心肺功能及生存质量影响的随机对照试验[J].中医杂志,2021,62(10):881-886.
[26] JEONG J H, HWANG J H.Herbal medicine for the prevention of sarcopenia: A protocol for systematic review[J]. Medicine (Baltimore),2021,100(14):25474.
[27] CHEN Y F, JIANG X J, WANG R, et al.Effects of electroacupuncture on skeletal muscle and blood glucose in rats with diabetic amyotrophy[J]. Zhongguo Zhenjiu,2020,40(6):629-634.
[28] 何兴伟,黄建华.痿证从督脉论治探讨[J].中国针灸,2008(3):231-233.
[29] ANTON S D, CRUZ-ALMEIDA Y, SINGH A, et al.Innovations in Geroscience to enhance mobility in older adults[J]. Exp Gerontol,2020(142):111123.
[30] 毛智慧,刘晓亭,张欢,等.健运脾胃法干预老年肌肉衰减综合征之机理探讨[J].辽宁中医杂志,2017,44(8):1631-1634.
[31] 李君子,毛静,王丽丽,等.补肺健脾方对COPD大鼠骨骼肌IGF-1、mTOR和h1f1-α的影响[J].中医学报,2018,33(2):268-273.
[32] 吴瑶,陈丝,宋囡,等.基于“脾运化–主肌肉”理论对线粒体脂肪酸氧化与脂质代谢关系的探讨[J].世界科学技术–中医药现代化,2020,22(6):2024-2028.
[33] MORAWIN B, TYLUTKA A, CHMIELOWIEC J, et al.Circulating Mediators of Apoptosis and Inflammation in Aging; Physical Exercise Intervention[J]. Int J Environ Res Public Health,2021,18(6):3165.
[34] 钱立锋,姚青,王晓燕,等.自拟黄芪葛根汤治疗实验性自身免疫性重症肌无力大鼠的免疫机制研究[J].浙江中医杂志,2018,53(8):570-571.
[35] 陈颖颖,何绪屏.健脾补肾法改善老年糖尿病肌少症患者胰岛素抵抗的临床研究[J].中国医药科学,2020,10(19):214-216.
[36] 杨静, 陈鹏. 经筋推拿改善老年肌少症患者下肢肌肉力量与质量临床观察[J]. 浙江中医杂志,2016,51(10):753.
[37] 张淑,袁明,吴士文.血府逐瘀胶囊对模拟失重下骨骼肌萎缩的防护作用[J]. 中华灾害救援医学,2016,4(11):618-623.
[38] PILAT Z, BERNATOVA S, JEZEK J, et al.Microfluidic Cultivation and Laser Tweezers Raman Spectroscopy of E-coli under Antibiotic Stress[J].SENSORS, 2018,18(16235).
[39] YOGESHA M, CHAWLA K, BANKAPUR A, et al.A micro-Raman and chemometric study of urinary tract infection-causing bacterial pathogens in mixed cultures[J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY,2019,411(14):3165-3177.
[40] GUO C Y, MA Y J, LIU S T, et al.Traditional Chinese Medicine and Sarcopenia: A Systematic Review[J]. Front Aging Neurosci,2022(14):872233.
[41] 杜来义,黄捷,汪桂青,等.慢性心力衰竭合并肌少症的中医诊治思路探讨[J].中医研究,2020,33(10):9-12.
[42] 方磊,李振瑞,陶旭辰,等.易筋经对老年骨骼肌减少症平衡障碍患者跌倒风险影响的临床研究[J].中国康复医学杂志,2020,35(3):319-323.
[43] 苏中军,姜军.太极拳锻炼对肌力改善效果的meta分析[J].中国康复医学杂志,2020,35(4):475-481.
[44] HARVEY N C, ORWOLL E, KWOK T, et al.Sarcopenia definitions as predictors of fracture risk independent of fRAX,falls,and BMD in the osteoporotic fractures in men (MrOS) study: a meta-analysis[J]. J Bone Miner Res,2021,36(7):1235-1244.
[45] 中国康复医学会康养工作专家委员会.中国老年人肌少症临床康复治疗指南[J].加速康复外科杂志,2022,5(1):1-7.